Researchers at Houston Methodist say they were able to build a personalized “Trojan horse” nanocarrier that effectively avoided destruction and delivered an…

The ERK1/2 pathway is a problem for about a third of all colorectal cancer patients.

The feds slammed the brakes on the production of experimental drugs at two of its facilities--including cell therapies that Kite's Steven Rosenberg works…

Scientists at Harvard's Wyss Institute have been working on human "organs-on-a-chip" technology in order to pioneer new therapies and predict…

Israel's BioLineRx has unveiled positive preclinical data for its experimental treatment for chronic myeloid leukemia, a progressive blood and bone…

Researchers have found a new possible way to treat cancer by exploiting a biological weakness in the most commonly mutated gene involved in human cancers.…

New genes identified by scientists at the University of Louisville in Kentucky may indicate a person's predisposition to excess abdominal fat, which…

Researchers at Vanderbilt University have discovered promising drug targets for previously hard-to-treat kinds of melanoma, suggesting that some cancers…